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Background: The genus Mycobacterium (M.) comprises highly pathogenic bacteria such as M. tuberculosis as well as
environmental opportunistic bacteria called non-tuberculous mycobacteria (NTM). While the incidence of
tuberculosis is declining in the developed world, infection rates by NTM are increasing. NTM are ubiquitous and
have been isolated from soil, natural water sources, tap water, biofilms, aerosols, dust and sawdust. Lung infections
as well as lymphadenitis are most often caused by M. avium subsp. hominissuis (MAH), which is considered to be
among the clinically most important NTM. Only few virulence genes from M. avium have been defined among
other things due to difficulties in generating M. avium mutants. More efforts in developing new methods for
mutagenesis of M. avium and identification of virulence-associated genes are therefore needed.
Results: We developed a random mutagenesis method based on illegitimate recombination and integration of a
Hygromycin-resistance marker. Screening for mutations possibly affecting virulence was performed by monitoring
of pH resistance, colony morphology, cytokine induction in infected macrophages and intracellular persistence. Out
of 50 randomly chosen Hygromycin-resistant colonies, four revealed to be affected in virulence-related traits. The
mutated genes were MAV_4334 (nitroreductase family protein), MAV_5106 (phosphoenolpyruvate carboxykinase),
MAV_1778 (GTP-binding protein LepA) and MAV_3128 (lysyl-tRNA synthetase LysS).
Conclusions: We established a random mutagenesis method for MAH that can be easily carried out and combined
it with a set of phenotypic screening methods for the identification of virulence-associated mutants. By this
method, four new MAH genes were identified that may be involved in virulence.
Keywords: Mycobacterium, Mycobacterium avium subsp. hominissuis, Non-tuberculous mycobacteria, Virulence,
Mutagenesis, Illegitimate recombinationBackground
The genus Mycobacterium (M.) comprises highly patho-
genic bacteria such as M. tuberculosis as well as environ-
mental opportunistic bacteria called NTM. They are
ubiquitous and have been isolated from soil, natural
water sources, tap water, biofilms, aerosols, dust and
sawdust [1-3]. Remarkably, NTM are resistant to
amoeba and protected against adverse conditions inside
amoebal cysts [4]. While the incidence of tuberculosis is
declining in the developed world, infection rates by
NTM are increasing [5]. NTM cause skin infections,* Correspondence: Lewina@rki.de
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reproduction in any medium, provided the orlung diseases, lymphadenitis and disseminated disease
mostly in immuno-compromised persons [5]. Lung
infections as well as lymphadenitis are most often caused
by M. avium [5,6], and M. avium is considered to be
among the clinically most important NTM [7].
M. avium can be divided into four subspecies. M.
avium subsp. paratuberculosis (MAP) causes the Johne’s
disease in ruminants; M. avium subsp. avium (MAA)
and M. avium subsp. silvaticum infect birds; and finally
M. avium subsp. hominissuis (MAH) which causes dis-
ease in humans [8].
The main route of infection in AIDS patients is the in-
vasion of mucosal epithelial cells of the gastrointestinal
tract, while in non-AIDS patients infections mainly
occur through the respiratory route [9]. Recognition ofLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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20 – 25 kDa lipoprotein from the cell envelope of M.
avium to TLR2. This interaction leads to bacteriostasis
of M. avium in a MyD88-dependent way [10]. Even
though the expression of TNF-α is also induced via
TLR2-signalling, its role in growth restriction of M.
avium is unclear [10]. IFN-γ is considered to be a key
cytokine for killing of M. avium and its expression is
promoted by IL-18 secreted by M. avium-infected
human macrophages [11]. Phagocytosis of M. avium is
supposed to be mediated via binding of the bacteria to a
variety of receptors including complement receptors
CR1, CR2, CR3, CR4, the mannosyl-fucosyl-receptor, the
fibronectin receptor, the integrin receptor α(v)β3, and
the transferrin receptor [12-15]. M. avium inhibits the
acidification of the phagosome and the fusion of the
phagosome with lysosomes [16,17].
Intracellular M. avium survives antibacterial activities
such as nitric oxide and reactive oxygen species and the
mechanisms leading to killing of M. avium are still un-
known [18]. The cell wall structure is an important fac-
tor determining virulence of M. avium [19]. Thus,
different colony morphotypes (smooth opaque, smooth
transparent, rough) distinguishable on Congo Red plates
display different degrees of virulence. Smooth transpar-
ent and rough colonies are considered to be more viru-
lent than smooth opaque colonies [20,21]. The colony
morphotype is associated with the glycopeptidolipid
(GPL) composition [19]. By inducing the release of vari-
ous pro-inflammatory cytokines such as IL-1, IL-6 or
TNF-α, GPL modulate the immune response against
mycobacteria [22].
Only relatively few virulence genes from MAH have
been defined with respect to their role in infection. This
is partly attributable to difficulties in generating MAH
mutants. The major obstacle is the low transformation
frequency if MAH is used as recipient. This also limits
the efficiency of so far described random mutagenesis
systems, such as the commercially available EZ-
TN<KAN2>Tnp Transposome from Epicentre. This
Tn903-based system consists of a stable complex formed
between the EZ::TN Transposase enzyme and the EZ::
TN<KAN-2 >Transposon. It was used in MAA and
MAH to analyse mechanisms of multidrug resistance
and the role of GPL [23-25]. Another system for the
generation of random mutants is based on transduction
using temperature-sensitive phages containing a trans-
poson with a selection marker [26,27]. In other myco-
bacterial species such as M. tuberculosis and M. bovis
BCG linear recombination substrates have been applied
to generate random as well as site-directed mutants
[28-30]. This approach, however, so far has not been
published for mutagenesis of MAH or MAA. With the
present study we intended to explore the performanceof illegitimate recombination of a linear recombination
substrate for random mutagenesis of MAH.
Methods
Bacterial strains, amoeba, cell lines and growth conditions
Mycobacterial strains were grown in Middlebrook (MB)
7H9 broth (BD Biosciences, USA), supplemented with
either 10% ADC (BD Biosciences) or 10% OADC (BD
Biosciences) and 0.05% Tween 80 without shaking, and
on MB 7H11 agar (BD Biosciences) at 37°C. Escherichia
coli DH5α was used as host strain for plasmid pYUB854,
a cosmid vector with a Hygromycin resistance (Hygr)
gene [31] and was cultured in/on Luria-Bertani broth
and agar at 37°C. Antibiotics when required were added
at the following concentrations: Kanamycin (50 μg ml-1)
or Hygromycin (50 μg ml-1). For Congo Red plating agar
media was supplemented with 100 μg ml-1 Congo Red.
The Acanthamoeba castellanii strain 1BU group II [32]
was cultivated in PYG medium (Proteose peptone-Yeast
extract-Glucose [33]) at 28°C and passaged once per
week. The human macrophage cell line THP-1 (DSMZ-
No. ACC-16, DSMZ GmbH, Braunschweig, Germany)
was maintained by passaging twice weekly in RPMI 1640
(GIBCOW Invitrogen, Darmstadt, Germany) supplemen-
ted with 10% foetal bovine serum (Bio Whittaker, Walk-
ersville, MD, USA). Cells were cultured in BD FalconTM
75 cm2 trays (BD Biosciences) at 37°C and in 5% CO2.
For human macrophages infection and washing, Iscove's
Modified Dulbecco's Media (IMDM) (PAA laboratories,
Austria) with 3% Human AB-serum (PAA laboratories)
was used.
Molecular biology techniques
All molecular biology techniques were carried out accord-
ing to standard protocols [34] or according to the recom-
mendations of the manufacturers of kits and enzymes.
Primers were purchased from Metabion (Martinsried,
Germany). Plasmid DNA was isolated with the QIAGEN
Plasmid Mini Prep Kit (Qiagen, Hilden, Germany). Poly-
merase chain reaction (PCR) was performed with the
DreamTaq Kit from Fermentas (St. Leon-Rot, Germany).
Restriction enzymes were purchased from Fermentas. For
elution of DNA fragments from agarose gels, the
QIAquick Gel Extraction kit (Qiagen) was used. Ligation
reactions were performed with the T4 DNA Ligase Kit
from Fermentas. Genomic DNA from mycobacteria was
isolated according to the protocol described in Sjöbring
et al. [35]. Sequencing reactions were performed by using
the Prism Big Dye FS Terminator Cycle Sequencing Ready
Reaction Kit from PE Applied Biosystems (Darmstadt,
Germany). Nucleotide sequence analysis was performed
using the software packages MacVector™ 7.2.3 (Accelrys,
Cambridge, UK) and Lasergene (DNASTAR, Inc.,
Madison, WI, USA).
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Mycobacterium were digested with ApaI or SmaI, sepa-
rated by electrophoresis in a 1% agarose gel and capillary
transferred to positively charged nylon membranes (GE
Healthcare, Buckinghamshire, UK) by following a stand-
ard protocol [34]. An 1818 bp region of the plasmid
pYUB854 carrying the Hygr gene was amplified using
the primer pair Hyg2K FW (5´-CAC CGT ACG TCT
CGA GGA ATT CCT G-3´) and Hyg2K BW (5´-GCG
TCG TGA AGA AGG TGT TGC TGA-3´) and the
digoxigenin labeling Kit (Roche, Mannheim Germany).
The labeled PCR-product was used as a probe and de-
tection was carried out using anti-digoxigenin-AP conju-
gate and CDP-star (Roche) according to the
manufacturers’ instructions.
Reverse PCR was applied to exactly locate the inser-
tion sites of the Hygr gene in the mutants. 2 μg of DNA
of each mutant was digested with the restriction enzyme
ApaI or SmaI (which do not cut in the recombination
substrate). The multiple sized DNA fragments were
ethanol precipitated and then self-ligated by T4 DNA
ligase enzyme, thus resulting in different sized circular
DNA molecules. A PCR was then performed with pri-
mers [Hyg mut_1 (5´-AAC TGG CGC AGT TCC TCT
G-3´) and Hyg mut_2 (5´-TCA GCA ACA CCT TCT
TCA CGA-3´)] binding within the Hygr gene and
oriented towards the unknown genomic MAH DNA
located adjacent to the Hgyr gene. Sequencing of the
PCR products using the primers Hyg mut_1 and Hyg
mut_2 followed by BLAST analysis of the sequences
allowed the exact identification of the insertion sites of
the recombination substrates.
For quantitative RT-PCR the mutants were grown in
MB/ADC with 25 μg ml-1 of Hygromycin B to an OD600
of 2. The pellet of 10 ml of culture was resuspended in
4 ml of protoplasting buffer (15 mM of Tris–HCl pH 8,
0.45 M of Sucrose, 8 mM of EDTA) with 4 mg ml-1
Lysozyme. After incubation at 37°C for 45 minutes
(min) the protoplasts were harvested by centrifugation
and the pellets were resuspended in 1050 μl of the RLT
buffer from the RNeasy Minikit (Qiagen) with 10.5 μl of
ß-Mercaptoethanol. This suspension was transferred
into tubes containing 25–50 mg of glass beads (0.5 mm,
PeqLab, Erlangen, Germany) and shaken in the
homogenizer Precellys 24 (PeqLab) for 45 sec at 6,500 g.
The tubes were chilled on ice and centrifuged at 8,000 g
for 5 min at 4°C. Then, 0.7 volume of absolute Ethanol
was added to the supernatant and this solution was dis-
tributed onto two columns of the RNeasy Kit. The sam-
ples were further processed as described in the RNeasy
manual. Residual DNA present in the RNA preparations
was removed with the Kit Desoxyribonuclease I (DNaseI)
RNase free from Fermentas. The M-MLV Reverse Tran-
scriptase and Random primers from Promega (WI, USA)were used to transcribe cDNA from the RNA. The
cDNA was then used to perform real time PCR with the
MaximaTM SYBR Green/Rox qPCR Master Mix 2x from
Fermentas. Primers were (i) for gene MAV_1779: 5´-
CTG CAG AAG AGC GTC TAC CC-3´ and 5´-CTC
TGT TCG GAG GTC GTC AT-3´, (ii) for gene
MAV_3129: 5´-GGT CAA GAC CAT CGA CGA CT-3´
and 5´-AGA TCA TGA ACG GCA CAA CA-3´, (iii) for
gene MAV_4332: 5´-ATG GTC GAG CAG AGC ATC
TGG-3´ and 5´-ATG GCG TCC ACG AAC CG-3´, (iv)
for gene MAV_5105: 5´-GTT GTC GAG TTC ACC
GGT CT-3´ and 5´-ATT CAC TCG GCG AAT ACC
TG-3´ and (v) for 16S rRNA gene: 5´-GAG TGA GAA
TGC AGG CAT GA-3´ and 5´-ACA CGG GTA CGG
GAA TAT CA-3´. The ΔΔCT method was used to calcu-
late the relative expression of the gene of interest in the
mutant in comparison to the mean of its expression in
the other three mutants. Normalisation was obtained by
measuring the expression of 16S rRNA gene as reference
gene.
Random mutagenesis by illegitimate recombination
1 μg of plasmid pYUB854 DNA was double digested
with restriction enzymes StuI and SpeI Fast digest at
37°C for 30 min. The 2030 bp linear DNA fragment
carrying the Hygr gene was gel-eluted after electrophor-
esis and 3–6 μg linear DNA fragment was transformed
into M. avium strains by electroporation with the
Biorad GenePulser apparatus applying 1000 Ω, 25 μF
and 1.25 kV in 1 mm gap cuvettes. The preparation of
electrocompetent cells and electroporation were per-
formed using standard protocols [36]. Plasmid pMN437
was used as positive control for transformation [37].
Electroporated bacteria were incubated at 37°C for
24 hours (h) before plating on selective plates. Potential
mutants were characterised by PCR amplifying a part of
the Hygr gene [primers Hyg 2 K LC FW (5´-AGT TCC
TCC GGA TCG GTG AA-3´) and Hyg 2 K LC BW
(5´-AGG TCG TCC CGG AAC TGC TGC G-3´)],
Southern blotting, reverse PCR (primers Hyg mut 1
and Hyg mut 2) and sequencing.
Construction of a complemented derivative of mutant
MAV_3128
Primers MAV3128_MV306_1 (5´-CGG TCT AGA CTA
TGC CTA CCT GCT CTC-3´) and MAV3128_MV306_2
(5´-GCA GTT AAC CTA ATG CGG CTT GGC CAG-
3´) were designed to amplify the gene MAV_3128
(3227 bp) plus 680 bp of upstream sequence of the wild
type with pfu polymerase from Fermentas. The amplified
product was cloned into the restriction sites XbaI and
HpaI respectively of the integrative vector pMV306 [38].
The recombinant plasmid pFKaMAV3128 was trans-
formed into E. coli DH5α by a method already described
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introduced into competent cells of mutant MAV_3128 by
electroporation. PCR analyses with the primer pair
MAV3128_MV306_1 and 2 confirmed the presence of
wild type gene in the mutant MAV_3128.
Screening for virulence-mutants
Amoeba Plate Test (APT)
The APT was previously described [40]. In short, known
concentrations of Acanthamoeba castellanii (1BU group
II strain) diluted in PYG medium were spread on MB
agar plates and these plates served as test plates. For
control plates only PYG medium without amoeba was
spread on MB agar plates. Plates were dried and incu-
bated at room temperature. The next day series of ten-
fold dilution (1:10, 1:100, and 1:1000) in sterile water
were prepared from cultures of the mutants and the M.
avium 104 wild type (WT). 3 μl of undiluted culture and
of each dilution were spotted onto the test and control
agar plates. Plates were then incubated at 30°C for one
week. Mutants showing reduced growth on test plates
compared to the control plates were selected for further
molecular characterisation.
Growth rate in broth cultures under pH stress
The growth rates of mutants and WT were compared in
MB 7H9 broth with neutral pH (7) and under pH stress
(pH 5). Cultures were inoculated to an initial OD600 of
0.02 to 0.03 and allowed to grow for two weeks. Three cul-
tures per strain were inoculated. Growth of cultures was
determined by measurement of OD600 of cultures and also
by quantification of ATP with the luminescence-based Kit
BacTiter-GloTM Microbial Cell Viability Assay (Promega).
The luminescence was recorded as relative light units
(RLU) with the microplate luminometer LB96V (EG & G
Berthold). Mutants showing differences of growth pattern
compared to the WT in both neutral medium and under
pH stress conditions were considered for further molecu-
lar characterisation.
Congo Red plating
100 μl of 1:105 and 1:106 dilutions in sterile water of
mutants, complemented strain and WT were spread in
triplicate on MB agar plates supplemented with OADC
and 100 μg ml-1 Congo Red. Plates were incubated for
2–3 weeks and observed for colony morphology.
Mutants showing differences in colony morphology
(white vs. red staining, transparent vs. opaque colonies,
smooth vs. rough colonies) compared to the WT were
considered for further molecular characterisation.
Induction of cytokine expression in THP-1 cells
Infection of the cell line THP-1 was performed in 24-well cell
culture plates (TPP) with three to five wells per sample. Atotal of 200,000 cells per well of THP-1 were grown along
with addition of phorbol-12-myristate-13-acetate (PMA,
Sigma, Taufkirchen, Germany) (10 ng ml-1) and allowed to
adhere to the surface of the plate well overnight at 37°C and
in 5% CO2. Cells were then infected with mutants and WT
at a multiplicity of infection (MOI) of 50 colony forming
units (CFU). The supernatants were removed after 24 h and
cytokines were quantified in appropriate dilutions of the
supernatants by ELISA using the Human ELISA Ready to go
Kits (Natutec, Frankfurt, Germany).
Intracellular survival in THP-1 cells
THP-1 cells were seeded, treated with PMA and infected
as described above. The supernatants were removed after
4 h infection period and adherent cells were washed twice
with RPMI 1640. The cells were then treated with
200 μg ml-1 of Amikacin (Sigma) for 2 h to kill the myco-
bacteria in the supernatant. After washing twice with PBS
buffer (10 mM sodium phosphate, 126 mM sodium chlor-
ide, pH 7.2), 1 ml of medium supplemented with 5 μg ml-1
of Amikacin was added to each well. Samples for quantifi-
cation of intracellular bacteria were taken at the end of the
infection time after removal and killing of extracellular
bacteria and then after 1, 2, and 4 days. For this, the cells
were lysed in 1 ml of water at 37°C for 20 min and the
mycobacterial DNA in the lysates was quantified by real-
time PCR as described in Lewin et al. [41]. Additionally,
100 μl of 1:103 dilution in sterile water of samples were
plated in triplicate on agar plates supplemented with ADC
for counting of CFU.
Intracellular survival in human monocytes
Human monocytes were isolated from buffy coats from
healthy donors using Ficoll-PaqueTM Plus (GE Health-
care) and PercollTM (GE Healthcare) gradient centrifuga-
tion according to the manufacturer’s recommendations
and as described in Sharbati et al. [42]. One million
macrophages were seeded per well in 24-well cell culture
plates, with three to five wells per sample per sampling
point. Infection with mutants, complemented strain and
WT, Amikacin treatment and sampling were done as
described above for THP-1 cells infection, except that
human monocytes were pre-activated with 100 U ml-1 of
human IFN-γ (Invitrogen, Darmstadt, Germany) and
10 ng ml-1 of LPS (Sigma), IMDM was used for washing,
the MOI for infection was 10 and the dilution of the
samples for plating and counting of CFU was 1:500.
Results and discussion
Generation and genetic characterisation of M. avium
mutants
Our aims were the establishment of a new method to
mutagenise MAH and the identification of mutants po-
tentially affected in virulence. The mutagenesis approach
Figure 1 Sketch showing randomly mutated genes distributed
within the M. avium genome. Genes location mapped on the
genome after sequencing.
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electroporation into MAH, and we therefore first identi-
fied clinical and environmental MAH strains applicable
to electroporation. We considered a prior investigation
of transformability to be necessary, because other
authors had reported some clinical M. avium strains to
be inaccessible to electroporation [43]. As proposed by
Lee et al. [43], we chose a gfp-containing plasmid
(pGFP: gfp cloned in vector pMV261 [38]) for trans-
formation assays. We tested 14 clinical isolates and two
soil isolates. Strain M. avium 104 was originally isolated
from an HIV patient [44] and strains 2721/04, 10091/06,
10203/06, 4557/08, 4023/08, 3646/08, 3449/08, 3269/08,
2630/08, 2014/08, 772/08, 709/08, 528/08 were isolated
from children with lymphadenitis. Strains 128 and 129
are soil isolates. Out of these 16M. avium strains, five
(104, 2721/04, 2014/08, 4023/08 and 528/08) could be
transformed with pGFP. As the genome sequence from
M. avium strain 104 is available in the genome data
bases, simplifying a precise mutant description, we
decided to concentrate on this strain for further analysis.
Our mutagenesis approach took advantage of the high
rate of illegitimate recombination in slow growing myco-
bacteria [28,45] and their ability to take up linear DNA
[29]. For selection purposes we chose the Hygr gene in-
stead of also often used Kanamycin resistance gene
(Kmr), because the Hygr gene had been shown before to
be superior to the Kmr gene especially for the transform-
ation of other than laboratory strains [46]. The Hygr
gene used for electroporation was flanked by plasmid
DNA of 793 bp on one side and 238 bp on the other
side. These flanking regions served as substrates for
the illegitimate recombination. After electroporation of
3–6 μg of restriction fragment and selection on plates
containing Hygromycin, about 1000 colonies could be
obtained. Around ten percent of this number appeared
on the negative control plates (no DNA added) and
had to be considered spontaneously resistant. The
positive controls (with 1–2 μg plasmid DNA) gener-
ated around 5–6 times more colonies than could be
observed on the test plates. Transposon/transduction
mutagenesis procedures have been reported to deliver
around 1,000 to 3,500 mutants per mutagenesis pro-
cedure [19,23,24,27,47,48] which means that the effi-
ciency or our method was below the efficiency of
transposon/transduction systems. Taking into account
the simple handling of our method we consider it
nevertheless to be a good alternative to the currently
applied methods for mutagenesis of MAH.
Fifty randomly chosen colonies from the sample plates
were tested for insertion of the Hygr gene by performing
a PCR using the primers Hyg 2 K LC FW and Hyg 2 K
LC BW (data not shown). By this PCR 49 of the 50 col-
onies could be confirmed to carry an insertion of theHygr gene in the genome. Additionally, Southern blots
using a PCR fragment produced with primer pair Hyg2K
FW and BW as probe were performed to verify if the
insertions had occurred at different genome sites in dif-
ferent colonies (data not shown). Hybridising bands
were obtained with the DNA from 20 colonies and con-
firmed independent insertion events.
Inverse-PCR using the primers Hyg mut 1 and Hyg
mut 2 followed by sequencing of the PCR products
enabled us to identify the sites of insertion of the Hygr
gene in 13 mutants. As shown in Figure 1, there were no
hot spots for integration but the insertions were distrib-
uted within the whole M. avium genome.
The genetic characterisation of four virulence-
associated mutants is shown in Figure 2. The integration
events were accompanied by deletions in all 13 mutants.
The smallest deletion had a size of 2 bp, the largest one
of 669 bp. All insertions were located within coding
regions. Only in one mutant more than one gene was
affected by the insertion. In 12 of the 13 mutants the lin-
ear recombination substrate had been completely
inserted and in one mutant the inserted fragment had
been shortened at both ends. The sequences next to the
inserted fragment showed no special structure or nu-
cleotide sequences.
Both, the random distribution of insertion sites and
the low rate of large deletions affecting more than one
gene are benefits of our method. Contrary to our experi-
ence with MAH, Collins and colleagues [49] observed
more clustered insertions and deletions of up to 12
Figure 2 Sketch illustrating the genetic characterisation of the mutants MAV_1778, MAV_3128, MAV_4334, and MAV_5106. The sites of
the insertion of the marker (Hygr gene) were identified by inverse PCR followed by sequencing of the eluted PCR products. The figure shows for
four mutants the mutated gene (dark blue) with the site of insertion of the fragment (grey) carrying the Hygr gene (red) and the four genes
located upstream and downstream of the mutated gene (light blue). Numbers in the arrows indicate the gene names. The direction of the
arrows stands for gene direction. Gene sizes and distances between genes are approximations. Below the map of each mutant the size of the
deletion generated as result of insertion of the marker is indicated.
Table 1 Mutated M. avium genes and their functions
Mutated Gene Function of the gene
MAV_2555 Short-chain dehydrogenase/reductase SDR
MAV_1888 Hypothetical protein
MAV_4334 Nitroreductase family protein
MAV_5106 Phosphoenolpyruvate carboxykinase
MAV_1778 GTP-Binding protein LepA
MAV_3128 Lysl-tRNA synthetase (LysS)
MAV_3625 Hypothetical protein
MAV_2599 Hypothetical protein
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carrying a Kanamycin resistance gene by illegitimate re-
combination. It would be interesting to find out the rea-
sons for these differing outcomes. Are the specific
parameters of the illegitimate recombination events
species-specific or does the composition of the recom-
bination substrate play a more important role?
In favor of a straight forward procedure, we concen-
trated our further efforts on those mutants, which ful-
filled the following requirements: - an insertion in the
middle of the coding region of a gene, – mutation of
only one gene and - mutation of a single copy gene.
After applying these criteria, eight mutants (see Table 1
for mutated genes and their functions) were selected for
phenotypic analysis.
Phenotypic characterisation of MAH mutants
Since virulence is regulated on many different levels we
applied more than one screening test (as for example
intracellular multiplication) to identify a greater
spectrum of relevant virulence-associated genes. We
searched for phenotypic assays allowing a fast screening
of our mutants and not requiring special and expensive
equipment. The selected tests should monitor changes
in (i) cell wall composition (plating on Congo Red Agar),
(ii) resistance towards low pH, (iii) amoeba resistance,
(iv) induction of cytokine secretion by infectedmacrophages and (v) intracellular survival and growth in
human macrophages.
Colony morphology and Congo Red staining characteristics
The occurrence of different colony morphotypes is an
eye-catching feature of M. avium including MAH and
has attracted attention also because it is associated to
virulence [19,24,50,51]. The colony morphology is influ-
enced by the composition of the cell wall, which is a
major determinant of mycobacterial virulence [52-54].
Congo Red, a planar hydrophobic molecule can bind to
diverse lipids and lipoproteins and is thus applicable for
the detection of changes in cell wall composition [54-56].
Upon plating of MAH on Congo Red agar plates, smooth
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as red and white colonies can be distinguished. Appear-
ance of the three morphotypes smooth opaque, smooth
transparent and rough was also confirmed for strain 104
[21]. While the opaque-transparent switch is reversible,
the rough phenotype results from irreversible deletion of
cell envelope glycopeptidolipid genes and is irreversible
[24,51].
TLC (Thin Layer Chromatography) analysis of the dif-
ferent morphotypes from strain 104 has been performed
by Torelles [21]. They also analysed the sugar compos-
ition of the glycopeptidolipids (GPL) by gas chromatog-
raphy–mass spectrometry (GC–MS) analysis. They
found that the smooth opaque and smooth transparent
colonies formed similar GPL and both expressed besides
the nsGPL (ns: non-specific) the ssGPL (ss:serovar spe-
cific) of serovar 1. However, the ssGPL was absent in the
rough morphotype, which had a strong band of the
nsGPL. A band in the lipopeptid region devoid of sugars
was present in the smooth transparent morphotype and
the rough morphotype but lacking in the smooth opaque
morphotype. The sugar composition of all morphotypes
showed the typical profiles related to ns and ssGPL of
serovar 1, only in the rough morphotype 6-deoxytalose
and 3-O-methyl-6-deoxytalose were missing.
The transparent colony variant grows better in macro-
phages and animals compared to the opaque variant. More-
over, white transparent colonies survived better in
macrophages than red transparent colonies [19,24,50,51,56].
These differences in intracellular survival may be caused by
variations in the cytokine response towards infection by dif-
ferent morphotypes. The smooth opaque morphotype has
been shown to induce higher levels of secretion of IL-1α, IL-
1β and TNF-α by human blood-derived monocytes com-
pared to the smooth-transparent morphotype [57]. Variation
in cytokine response upon infection with either smooth-
opaque or smooth-transparent M. avium was also reported
upon infection of human microglia cultures [58].
The colony morphology of the WT and the mutants
upon plating on Congo Red Agar is shown in Figure 3.
The WT (Figure 3 A) mainly formed smooth-domed-
opaque (sdo) colonies along with smooth-transparent
(st) colonies. Mutant MAV_2555 showed the same
morphologies, but additionally smooth-flat-red (sfr) col-
onies were visible (Figure 3 B). Relatively few smooth-
transparent and rough colonies occurred in mutant
MAV_1888 (Figure 3 C), MAV_4334 (Figure 3 D) and
MAV_5106 (Figure 3 E). Mutant MAV_4334 (Figure 3
D) showed a higher variation with respect to the inten-
sity of red color of smooth-domed-opaque colonies. Mu-
tant MAV_1778 showed a very high degree of variability
displaying red-rough (rr) and smooth-flat-red colonies
additionally to the smooth-domed-opaque, smooth-
transparent and rough-white (rw) colonies (Figure 3 F).The colonies generated by mutant MAV_3128 (Figure 3
G) were in average larger in size and the smooth-opaque
colonies appeared paler than in the WT. Also, the edges
of these colonies were more irregular. Some red-rough
colonies were also visible. The most multifaceted image
was displayed by mutant MAV_3625. This strain gener-
ated smooth-domed-opaque, smooth-domed-red (sdr),
smooth-flat-red, smooth-transparent and rough-trans-
parent (rt) and red-rough colonies (Figure 3 H). A
high proportion of red colonies (smooth-domed-red,
smooth-flat-red, red-rough) was generated by mutant
MAV_2599 (Figure 3 I) additionally to smooth-opaque
and smooth-transparent colonies. This mutant pro-
duced only few rough (rough-transparent, rough-red)
colonies. Altogether, we observed a high frequency and
intensity of morphological changes in the mutants
pointing to involvement of the mutated genes in the
composition of cell wall structure. Since studies by dif-
ferent authors have related colony morphotype to viru-
lence it would be of interest to investigate in further
experiments if and to which degree the different col-
ony types are stable and differ in their virulence.
pH-resistance
The intraphagosomal pH of M. avium-containing pha-
gosomes decreases to pH 5.2 in activated macrophages
[59]. We therefore investigated the pH-resistance of the
mutants compared to the WT by inoculating them into
MB broth at pH 5 and pH 7 and measuring the growth
during 11 days at 37°C by means of OD measurement
and ATP quantification. ATP measurement represents a
much more sensitive method than the OD measure-
ment. Additionally, the OD of a culture not only
depends on cell number but also on the size of the cells,
their morphology and the degree of clumping of the
cells. For these reasons, ATP measurement was reported
to be a more reliable method for quantification of myco-
bacteria in broth culture [41]. As shown in Figure 4, the
WT grew better at neutral pH than at low pH. After
11 days of growth in neutral medium, it generated
722,491 RLU (relative light units), while in medium with
acidic pH only 143,082 RLU were achieved. The mutants
MAV_2555, MAV_1888, MAV_4334 and MAV_5106
showed a similar growth pattern as the WT, both in
neutral and acidic pH (data not shown). The mutants
MAV_1778 and MAV_3128 grew similar as the WT at
neutral pH; however, at low pH these strains enhanced
their growth rate even above the level reached at neutral
pH (Figure 4 A and B). While the mutant MAV_3128
showed enhanced growth in comparison to the WT at
low pH already at day 1, the mutant MAV_1778 showed
an identical growth rate as the WT at low pH until day 5
and then showed strongly enhanced growth. The
mutants MAV_3625 and MAV2599 grew better than the
Figure 3 Colony morphology upon plating on Congo Red agar plates. Well-grown broth cultures of all strains were diluted 1:106 and 100 μl
plated in triplicate onto Middlebrook agar with OADC containing 100 μg ml-1 Congo Red. Plates were incubated on average for three weeks. The
arrows point to smooth-domed-opaque (sdo), smooth-flat-red (sfr), smooth transparent (st), rough red (rr) and rough transparent (rt) colonies. A:
WT; B: mutant MAV_2555; C: mutant MAV_1888; D: mutant MAV_4334; E: mutant MAV_5106; F: mutant MAV_1778; G: mutant MAV_3128; H:
mutant MAV_3625; I: mutant MAV_2599.
Figure 4 Resistance towards pH stress. The bacteria were grown in Middlebrook 7H9 broth with OADC at pH 7 and pH 5 during 11 days; the
ATP content was recorded by quantification of the amount of ATP in the cultures. The amount of ATP is represented as RLU (relative light units).
A: WT and mutant MAV_1778; B: WT and mutant MAV_3128; C: WT and mutant MAV_3625; D: WT and mutant MAV_2599.
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Figure 5 Induction of IL-10 cytokine secretion by infected
macrophages. THP-1 cells (2.0x105) were infected (MOI 50) with
mutants and WT. After 24 hours cytokines from supernatants were
measured by ELISA. When compared to WT a P value <0.01
(two-tailed, unpaired Mann–Whitney test) was considered very
significant (**).
Khattak et al. BMC Microbiology 2012, 12:204 Page 9 of 14
http://www.biomedcentral.com/1471-2180/12/204WT at pH 7 and were able to maintain this growth rate
at pH 5 (Figure 4 C and D). In summary, the mutations
either had no influence on the survival under pH stress
conditions or improved resistance towards pH stress.
Amoeba plating test
Free-living amoebae are known to host environmental
mycobacteria including M. avium, which are able to
survive in Acanthamoeba trophozoites as well as in
the exocysts [4,60,61]. Growth in Acanthamoeba was
associated with subsequently enhanced virulence in in-
fection experiments with mice [62]. Since some viru-
lence mechanisms are employed by amoeba-resistant
bacteria to survive in amoebae as well as in macro-
phages [4,63-65], amoebae have been used as test sys-
tems for determination of bacterial virulence factors
[40,63,66]. An Acanthamoeba castellanii agar plate
assay was developed and successfully employed for
screening of mutants of Legionella pneumophila [40].
We adapted this APT to fit the growth conditions
(medium, temperature, duration) of M. avium and tested
the eight mutants in comparison to the WT. After incu-
bation for five to seven days at 28°C, the WT formed col-
onies even if the cultures were diluted 1:103 before being
dropped on the lawn of amoebae. The growth of some
mutants was more strongly affected by the amoebae but
a differentiated evaluation of the impact of the various
mutations on survival in the amoebae was not possible
(data not shown). The APT thus was not sensitive
enough to reveal differences in the capacity of the
mutants to survive within the amoebae. This was surpris-
ing, because the APT has proven to be an efficient tool
for the identification of virulence genes in L. pneumophi-
lae [40]. There are several possible explanations for this
discrepancy. Amoebae are the most important habitat of
Legionella, while M. avium is not dependent on the pres-
ence of amoebae for survival and distribution. As a con-
sequence, Legionella might have evolved more important
virulence factors interacting with amoebae. Another pos-
sible explanation may result from the differences in the
generation times of L. pneumophilae and M. avium. L.
pneumophilae is a fast-growing bacterium forming
clearly visible colonies few days after plating, while the
slow-growing M. avium 104 requires two weeks to gen-
erate colonies of comparable size. This time span may be
too long to maintain the amoebae as trophozoites ac-
tively interacting with the mycobacteria. In conclusion,
we estimate the APT to be of only little value for the de-
tection of virulence genes of slow-growing mycobacteria.
Induction of cytokine secretion
The innate immune recognition by phagocytic cells med-
iates cellular activation enabling killing of the bacteria and
the production of pro- and anti-inflammatory cytokines.The signaling cascade is mainly initiated by binding of M.
avium components to TLR2 followed by recruitment of
the MyD88 adaptor molecule and the activation of NFκB
and MAP kinases. This chain of events ends with the in-
duction of inflammatory cytokines [10] controlling macro-
phage activation and granuloma formation. We monitored
the induction of cytokine expression of THP-1 macro-
phages by the WT and the mutants in order to evaluate
their ability to stimulate the immune signaling. To this
aim we quantified the secretion of selected cytokines: the
pro-inflammatory cytokines TNF-α, IL-1β and the anti-
inflammatory cytokine IL-10. Five independent experiments
were normalised for WT (expression ratio 1) to determine
the expression ratio for the mutants in comparison to WT.
While results for TNF-α and IL-1β were not significantly
different as compared to WT, IL-10 was significantly (P
<0.007) up-regulated for mutant MAV_4334 (Figure 5). IL-
10 can inhibit the production of inflammatory cytokines
such as TNF-α in monocytes pre-activated by IFN-γ and
LPS [67,68] and therefore plays an important role in the im-
mune response.
Intracellular survival
The ability to survive and even replicate inside the pha-
gosomes of macrophages is an important virulence fac-
tor of mycobacteria and was therefore included in our
screening options. Infection experiments with macro-
phages give information on the early host response to
mycobacterial infections [69]. Different types of macro-
phages or monocytic cells have been employed to assess
mycobacterial virulence and among these the human
macrophage-like cell line THP-1 has proven a suitable
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THP-1 cells are similar to primary human monocyte-
derived macrophages with respect to their ability to take
up mycobacteria and limit their growth [71]. We
infected THP-1 cells that had been differentiated by
PMA with the WT and the mutants. Intracellular myco-
bacteria were measured by quantitative real-time PCR
and CFU by plating. Survival of mutants in THP-1 cells
was not consistently different if compared to the WT
(data not shown). More significant differences were
obtained when using human blood monocytes for the in-
fection experiments. The growth of mutant MAV_4334,
MAV_1778 and MAV_3128 was affected the most in
human monocytes (Figure 6). They were reduced signifi-
cantly for the first two days (P < 0.05 to P < 0.01). Mutant
MAV_4334 and MAV_1778 (Figure 6 A and C) were al-
most reduced to half during the first two days. As shown
in Figure 6 D, mutant MAV_3128 had the highest sig-
nificant (P < 0.001) difference in growth as compared to
WT, which had survived better during this time period.
The mutant MAV_5106 largely differed from other
mutants and during four days of infection had shown
constant survival (Figure 6 B). The capacity of mutantFigure 6 Intracellular survival of mutants compared to WT in human
volunteers were infected (MOI 10) with mutants and WT. Intracellular bacte
The monocytes were lysed in 1 ml of sterile water and 100 μl of 1:500 dilu
supplemented with ADC for CFU counting. A: WT and mutant MAV_4334;
and mutant MAV_3128. Statistical analysis was done using a two tailed, pa
considered significant (*) and a P < 0.01 very significant (**).MAV_5106 to survive better in macrophages suggests
that it may be characterised by a higher virulence as
compared to the other mutants. Tateish et al. [70] com-
pared the virulence of different M. avium isolates in
humans, immuno-competent mice and THP-1 cells.
They found that the strain causing the most serious
disease in humans and the highest bacterial load in
mouse lungs also grew better in THP-1 cells than the
other strains tested. According to this, the mutants
MAV_4334, MAV_1778 and MAV_3128 may display
reduced virulence and the corresponding genes may rep-
resent virulence-associated genes.
Evaluation of the screening procedure
We have employed five screening methods (colony morph-
ology, pH stress resistance, amoeba resistance, cytokine in-
duction, intracellular survival) to select mutants affected in
virulence-related traits. Two mutants (MAV_4334 and
MAV_3128) responded differently from the WT in four of
these five screening tests and two mutants (MAV_5106 and
MAV_1778) reacted differently in three screening tests.
The most prominent differences were exhibited by mutant
MAV_3128. The other mutants either did not show anymonocytes. Human blood monocytes (1.0x106) from healthy
ria were quantified after 4 hour of infection, and after 1, 2, & 4 days.
tion in sterile water of sample were plated on Middlebrook agar plates
B: WT and mutant MAV_5106; C: WT and mutant MAV_1778; D: WT
ired Student’s t test. When compared to wild-type a P< 0.05 was
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only one or two tests.
The insertions in mutants MAV_4334, MAV_5106,
MAV_1778 and MAV_3128 have been mapped and the
structure of the mutated regions has been analyzed on
nucleotide level. In all cases only one gene has been
mutagenised. The insertions are located in the genes
MAV_4334 (nitrogenase reductase family), MAV_5106
(phosphoenolpyruvate carboxykinase), MAV_1778 (GTP-
binding protein LepA) and MAV_3128 (lysyl-tRNA
synthestase LysS).
Phosphoenolpyruvate carboxykinases (PEPCK) catalyse
the reversible decarboxylation and phosphorylation of
oxaloacetate to form phosphoenolpyruvate. Mutations of
the PEPCK gene from M. bovis BCG are characterised
by attenuated virulence and reduced survival in macro-
phages [72]. The PEPCK gene from M. tuberculosis was
shown to be required for replication in murine bone
marrow macrophages and mice [73].
The LepA protein from M. tuberculosis possess
GTPase activity. Bacterial GTP-binding proteins play a
role in regulation of ribosomal function and cell cycle,
modulation of DNA partitioning and DNA segregation
[74]. In Helicobacter pylori LepA is important for growth
at low pH and may play a role in infection [75].Figure 7 Phenotype of the complemented strain MAV3128Comp com
Congo Red plates. B: Intracellular survival in human blood monocytes.The lysS gene from M. avium is 81% homologous to
the lysX gene from M. tuberculosis. LysX from M. tuber-
culosis is required for synthesis of lysinylated phosphati-
dylglycerol. A LysX mutant was shown to be sensitive to
cationic antibiotics and peptides, to be more lysosome-
associated and to display defective growth in mouse and
guinea pig lungs [76].
So far, nothing is known about the role of the nitro-
genase reductase family protein for growth and patho-
genicity of mycobacteria and answering this question
will be one of our future aims.
In summary, by analysing 50 random mutants, we
uncovered four genes from MAH to play a role in the
interaction with host cells and thus in virulence. The
homologues of three of the four genes were shown to
contribute to virulence in other bacterial species, which
supports the significance of our screening procedure.
Mutant complementation and evaluation of polar
down-stream effects
To prove that the phenotypes of the mutants were in-
deed a cause of the inactivation of the mutated genes,
we aimed at complementing the mutants by introducing
the intact genes by electroporation. Only the transfer of
gene MAV_3128 into the respective mutant waspared to mutant MAV_3128 and WT. A: Colony morphology on
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and most different phenotypic changes in comparison to
wild-type among the eight tested mutants in almost all
the phenotypic tests. A complementation is best per-
formed if the copy number of gene transcripts generated
by the complementing gene narrows the copy number in
the wild-type. We therefore used a plasmid for cloning
(pMV306) that integrates once in the genome of the mu-
tant and included the upstream region of MAV_3128 to
most likely cover the promoter of the gene. This up-
stream region had a size of about 680 bp and the gene
MAV_3127, which is located upstream of MAV_3128,
has an orientation in opposite direction of MAV_3128
(see Figure 2). Therefore it was expected that the up-
stream region will contain the promoter sequence of the
MAV_3128 gene. Thus a 3907 bp DNA fragment was
cloned into the integrative vector pMV306. The result-
ing recombinant plasmid pFKaMAV3128 was success-
fully transformed into the mutant MAV_3128 to
generate the complemented strain MAV3128Comp.
Selected phenotypic tests (plating on Congo Red Agar
and intracellular survival) were repeated with the comple-
mented strain. Upon plating on Congo Red agar (Figure 7
A), the pale colour of mutant MAV_3128 could no longer
be seen in MAV3128Comp, except some pale corners in
colonies. This may indicate the loss of the plasmid in ab-
sence of selection pressure. The intracellular survival ex-
periment has also conclusively indicated a reversal of the
mutation. The complemented strain showed more similar
growth tendency towards wild-type strain than towards
the mutant (Figure 7 B). In conclusion we successfully
complemented the mutant MAV_3128 by introducing the
intact gene proving that the phenotype of mutant
MAV_3128 was indeed caused by the inactivation of gene
MAV_3128 and not by a second line mutation.
Since introduction of the intact genes into the other
three mutants failed we additionally investigated the oc-
currence of polar effects in the four mutants by quanti-
tative RT-PCR. As polar effects most probably will have
an impact on genes which are located downstream of
the mutated gene and exhibit the same orientation, we
quantified expression of genes MAV_1779 (in mutant
MAV_1778), MAV_3129 (in mutant MAV_3128),
MAV_4332 (in mutant MAV_4334) and MAV_5105 (in
mutant MAV_5106) by qRT-PCR. The 16S rRNA gene
was used as reference gene. The ΔΔCT method was used
to calculate expression of the gene in the corresponding
mutant compared to the mean expression in the other
three mutants. The expression levels measured were:
MAV_1779 (in mutant MAV_1778): 2.1 fold, MAV_3129
(in mutant MAV_3128): 1.1 fold, MAV_4332 (in mutant
MAV_4334): 1.0 fold and MAV_5105 (in mutant
MAV_5106): 1.4 fold. In three of the four mutants, the
expression of the down-stream genes transcribed in thesame direction was not or only slightly changed. Only in
mutant MAV_1778 a two-fold expression of gene
MAV_1779 was observed. We conclude that with one
exception no relevant polar effects could be observed.
Conclusions
Our study proposes a well-functioning method to ran-
domly mutagenise MAH, by illegitimate recombination,
genetically characterise the mutations to the nucleotide
level and screen the mutants with simple phenotypic
tests providing information about virulence-associated
features.
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